Furthermore, our analysis demonstrated in the TCGA database that in BC samples, reduced CACNA1D expression was associated with a significant reduction in disease-free survival (Supplementary Figure S1A,B) (HR: 1.604 (95% CI: 1.109–2.320), p < 0.0127, q < 0.0254). This evidence concerns the gene CACNA1D and breast cancer.